Company intelligence / Profile preview

Aurora Pharmaceutical

Northfield, Minnesota, United States

Ownership: Private
Employees: ~44
Development stage: Other

Overview

Aurora Pharmaceutical is a commercial-stage company developing and manufacturing proprietary and generic equivalent animal health products for livestock and companion animals, with approximately 35 product lines sold in at least three countries[3][5]. No clinical trial data applicable as it operates in the post-approval animal health market.

Therapeutic areas: Infectious DiseasesMetabolic DisordersDermatology
Modalities: Small moleculeBiologicNutritional supplementTopical treatmentAntimicrobial
Industry: Veterinary

Partnerships

Not publicly disclosed; primary relationships are with distributors, veterinary networks[1]

Beyond the preview

Go deeper on Aurora Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aurora Pharmaceutical.

Explore the full profile